Policy
25 February 2015 Vol 7 Issue 276 276fs8
BMC Res Notes (2016) 9:182 DOI 10.1186/s13104-016-1993-7
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
Brief instructions for the diagnostic of specimens coming from suspected plague cases and exposed contacts, including recommendations for diagnostic confirmation
J. European Academy of Dermatology and Venereology, 4 August 2014
Цель: оценить этиологическую структуру симптоматической эпилепсии, возрастную структуру периода манифестации заболевания, среднюю длительность латентного пери...да среди детей с различным характером повреждений, зависимость частоты приступов от характера повреждения. Материал и методы. Изучались 180 медицинских карт пациентов, имевших симптоматическую и криптогенную формы заболевания. Анализ заключался в оценке анамнестических данных, параметров ЭЭГ-исследований и нейровизуализации. Результаты. Установлено преобладание гипоксически-ишемической энцефалопатии в этиологической структуре заболевания. Возраст манифестации чаще приходился на период от года до 3 лет. Наиболее частой локализаци-
ей эпилептогенного очага явилась область височной и лобной доли. Наиболее длительный латентный период отмечен при ЧМТ, а наиболее короткий — при нейроинфекциях и последствиях внутриутробных инфекций. Заключение. Симптоматическая эпилепсия у детей является многофакторным заболеванием, течение и проявление которого в значительной мере зависят от инициального повреждения, вызвавшего данную патологию.
http://www.ssmj.ru/system/files/2014_02_318-319.pdf
more
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I...n this review, 46 therapeutic options are examined. The Pan American Health Organization (PAHO) is continually monitoring ongoing research on any possible therapeutic options. As evidence emerges, then PAHO will immediately assess and update its position, and particularly as it applies to any special sub-group populations such as children, expectant mothers, those with immune conditions, etc.
more
Ficha de Notificación e Investigación Epidemiológica Hepatitis Aguda Grave de origen Desconocido
Actualizatión 16.05.2022
In response to the recent publication “Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes” by Dadzie et al., it is important to clarify and highlight the positive and unequivocal research and operational contributio...ns from the American experience towards the worldwide elimination of human onchocerciasis (river blindness).
more
Mycetoma is a specific chronic, granulomatous, inflammatory disease. It usually involves the subcutaneous tissue, most probably after traumatic inoculation of the causative organism. It has a prolonged, progressive, and indolent course, and, if untreated, it ultimately leads to destruction of the de...eper tissues and bone, resulting in deformity and disability that may necessitate amputation of the affected parts with all the social and economic implications of this. The disease is characterized by tumefaction, draining sinuses, and the presence of grains.
more
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
of millions more. These diseases erode the health
and well-being of the patients and have a negative
impact on families and societies. Women ...and
children are particularly vulnerable, especially those
in low and middle income countries, where they are
exposed on a daily basis to indoor air pollution from
solid fuels for cooking and heating. In high income
countries, tobacco is the most important risk factor
for chronic respiratory diseases, and in some of
these countries, tobacco use among women and
young people is still increasing.
more